Squamous Cell Carcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy, radiation therapy, and gefitinib in patients with Stage III non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours [Phase 2]
Phase 2 proof-of-concept trial evaluating AZD4547 in FGFR1/FGFR2-amplified tumors, including gastric cancer, esophageal cancer, breast cance…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial evaluating AG-013736 with cisplatin and gemcitabine in patients with squamous non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) [Phase 2]
Phase II trial comparing maintenance temozolomide versus observation in stable or responding stage III/IV Non-Small Cell Lung Cancer. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment [Phase 2]
Phase II trial evaluating the combination of docetaxel and oxaliplatin as second-line therapy in advanced non-small cell lung cancer, includ…
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) [Phase 2]
Phase 2 study of bevacizumab plus carboplatin and paclitaxel in advanced, previously untreated squamous non-small cell lung cancer has compl…